BP
Brian T. Powl (Chief Commercial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Kura Oncology, Inc. (KURA). The largest single filing was $166K of KURA (15,430 sh × $10.75, as filed), executed Sep 29. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$276K
shares × price, as filed
Last traded
Sep 29
Filed Sep 29
Median ADV $20.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $276K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
KURA
Kura Oncology, Inc.
KURA · 0 buys · 2 sells
2 filings
Recent filings
KURASALE
Kura Oncology, Inc.
View filing →
$166K15,430 sh × $10.75
Exec Sep 29
Filed Sep 29 · 6:30 PM ET KURASALE Kura Oncology, Inc. View filing → $110K
10,000 sh × $11.00
Exec May 21
Filed May 22 · 5:30 PM ET